ロード中...
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
BACKGROUND: Tumor mesothelin overexpression is present in different malignancies, including the majority of patients with pancreatic or biliary cancers. The objective of this study was to evaluate the use of shed serum mesothelin and megakaryocyte potentiating factor (MPF) concentrations as biomarke...
保存先:
| 出版年: | Clin Chem Lab Med |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309905/ https://ncbi.nlm.nih.gov/pubmed/22149739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/CCLM.2011.816 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|